Phase 4
Completed N=24
Optimizing Local Anesthetic Concentration for Continuous Popliteal-Sciatic Nerve Blocks
Relatively Healthy Volunteers
Source: ClinicalTrials.gov NCT01898689 ↗
Enrolled (actual)
24
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcomePrimary: Maximum Tolerance to Transcutaneous Electrical Stimulation — 27.0; 26.9 mA (milliamperes) — p=0.02
◆ Published Evidence
Established
24citations · ~2 / year
A randomized, triple-masked, active-controlled investigation of the relative effects of dose, concentration, and infusion rate for continuous popliteal-sciatic nerve blocks in volunteers.
Summary
A continuous peripheral nerve block-also termed "perineural local anesthetic infusion"-involves the insertion of a tiny tube (a "catheter") through the skin and adjacent to a peripheral nerve, followed by local anesthetic (numbing medicine) administration via the catheter, providing pain control following surgery. Continuous peripheral nerve blocks may be provided in the hospital setting, but the use of lightweight, portable pumps permits infusion at home as well. However, it remains unknown if the concentration of the local anesthetic influences the block effects; or, is it rather simply the total dose of medication that is important. If it is the latter, then the concentration of local anesthetic could be increased, allowing a decreased basal infusion rate, which would allow patients at home to receive twice the duration of potent pain control since their infusion pump local anesthetic reservoir would last twice as long as current practice. In addition, if one concentration/dose combination results in less muscle weakness, but with at least equivalent analgesia, then the risk of falling might be decreased as well.
The investigators will test the hypothesis that providing ropivacaine at different concentrations and rates (0.1% at 8 mL/hour vs. 0.4% at 2 mL/hour)-but at an equivalent total basal (8 mg/hour)-produces comparable effects when used in a continuous popliteal-sciatic nerve block.
Linked Publications
-
A randomized, triple-masked, active-controlled investigation of the relative effects of dose, concentration, and infusion rate for continuous popliteal-sciatic nerve blocks in volunteers.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Maximum Tolerance to Transcutaneous Electrical Stimulation |
23; 22.5; 19; 20; 18; 19 | — |
| SECONDARY Maximum Tolerance to Transcutaneous Electrical Stimulation |
23; 22.5; 19; 20; 18; 19 | — |
| SECONDARY Percent of Maximum Voluntary Isometric Contraction Baseline (Quadriceps Femoris) |
100; 100; 90; 98; 8.1; 8.1 | — |
Eligibility Criteria
Inclusion Criteria
- age ≥ 18 years
- willing to have bilateral femoral perineural catheters placed with a subsequent ropivacaine infusion and motor/sensory testing for 6 hours, requiring an overnight stay in the UCSD GCRC/CTRI to allow dissipation of local anesthetic infusion effects by the following morning
Exclusion Criteria
- current daily analgesic use
- opioid use within the previous 4 weeks
- any neuro-muscular deficit of either femoral nerves and/or quadriceps muscles
- morbid obesity [weight > 35 kg/m2]
- pregnancy (as determined by a urine pregnancy test prior to any study interventions)
- incarceration
We expect to recruit a maximum of 30 healthy volunteers; with a target goal of 24 for the analysis. Selection for inclusion will not be based on gender, race, or socioeconomic status. The study population of interest includes men and women of all races and socioeconomic status. There will be no participants from vulnerable populations, such as pregnant women, children, or prisoners.
Data sourced from ClinicalTrials.gov (NCT01898689) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.